Simple coacervates and methods of use thereof
US-2018147316-A1 · May 31, 2018 · US
US10517987B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10517987-B2 |
| Application number | US-201815918423-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2018 |
| Priority date | Jan 24, 2008 |
| Publication date | Dec 31, 2019 |
| Grant date | Dec 31, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein is the synthesis of adhesive complex coacervates and their use thereof. The adhesive complex coacervates are composed of a mixture of one or more polycations and one or more polyanions. The polycations and polyanions in the adhesive complex coacervate are crosslinked with one another by covalent bonds upon curing. The adhesive complex coacervates have several desirable features when compared to conventional bioadhesives, which are effective in water-based applications. The adhesive complex coacervates described herein exhibit good interfacial tension in water when applied to a substrate (i.e., they spread over the interface rather than being beaded up). Additionally, the ability of the complex coacervate to crosslink intermolecularly increases the cohesive strength of the adhesive complex coacervate. The adhesive complex coacervates have numerous biological applications as bioadhesives and drug delivery devices. In particular, the adhesive complex coacervates described herein are particularly useful in underwater applications and situations where water is present such as, for example, physiological conditions.
Opening claim text (preview).
What is claimed: 1. A liquid adhesive complex coacervate, wherein the complex coacervate comprises at least one polycation and at least one polyanion, and wherein the complex coacervate does not include a multivalent cation. 2. The liquid adhesive complex coacervate of claim 1 , wherein the polycation comprises a polyamino compound. 3. The liquid adhesive complex coacervate of claim 1 , wherein the polycation comprises a polyacrylate having pendant amino groups. 4. The liquid adhesive complex coacervate of claim 3 , wherein the polyacrylate is a homopolymer or copolymer derived from the polymerization of an acrylate monomer comprising an acrylate, a methacrylate, an acrylamide, or any combination thereof. 5. The liquid adhesive complex coacervate of claim 1 , wherein the polycation comprises a polyacrylate comprising a primary, secondary, or tertiary amino group, an alkylamino group, a heteroaryl group, or an aromatic group substituted with one or more amino groups, or imidazole groups. 6. The liquid adhesive complex coacervate of claim 1 , wherein the polyanion comprises a polymer comprising pendant sulfate, sulfonate, carboxylate, borate, boronate, phosphonate, phosphate groups, or any combination thereof. 7. The liquid adhesive complex coacervate of claim 1 , wherein the polyanion comprises a polyphosphate compound. 8. The liquid adhesive complex coacervate of claim 1 , wherein the polyanion comprises an inorganic polyphosphate. 9. The liquid adhesive complex coacervate of claim 1 , wherein the polyanion comprises a metaphosphate salt. 10. The liquid adhesive complex coacervate of claim 1 , wherein the polyanion comprises a polyacrylate comprising pendant phosphate or phosphonate groups. 11. The liquid adhesive complex coacervate of claim 1 , wherein the polyanion comprises a naturally-occurring polyphosphate. 12. The liquid adhesive complex coacervate of claim 1 , wherein the complex coacervate further comprises a bioactive agent. 13. The liquid adhesive complex coacervate of claim 1 , wherein the polycation and polyanion comprises at least one group capable of covalent crosslinking with each other. 14. The liquid adhesive complex coacervate of claim 13 , wherein the crosslinking group on the polycation comprises a nucleophilic group and the crosslinking group on the polyanion comprises an electrophilic group. 15. The liquid adhesive complex of claim 13 , wherein the crosslinking group on the polycation comprises an electrophilic group and the crosslinking group on the polyanion comprises a nucleophilic group. 16. The liquid adhesive complex coacervate of claim 13 , wherein the crosslinking group on the polycation and polyanion comprises an ortho-dihydroxy aromatic group capable of undergoing oxidative crosslinking. 17. The liquid adhesive complex coacervate of claim 13 , wherein (1) the crosslinking group on the polyanion comprises a quinone group and the polycation comprises a nucleophilic group capable of reacting with the quinone group to form a covalent bond or (2) the crosslinking group on the polycation comprises a quinone group and the polyanion comprises a nucleophilic group capable of reacting with the quinone group to form a covalent bond. 18. The liquid adhesive complex coacervate of claim 17 , wherein the nucleophilic group is a hydroxyl, a thiol group, or a substituted or unsubstituted amino group. 19. The liquid adhesive complex coacervate of claim 13 , wherein the crosslinking group on the polyanion and the polycation comprises an actinically crosslinkable group. 20. The liquid adhesive complex coacervate of claim 19 , wherein the actinically crosslinkable group comprises an olefinic group. 21. The liquid adhesive complex coacervate of claim 20 , wherein the olefinic group comprises an acrylate group, a methacrylate group, an acrylamide group, a methacrylamide group, an allyl group, a vinyl group, a vinylester group, or a styrenyl group. 22. The liquid adhesive complex coacervate of claim 1 , wherein the coacervate further comprises an initiator and optionally a co-initiator. 23. The liquid adhesive complex coacervate of claim 22 , wherein the initiator comprises (1) one or more of a radical initiator, a thermal initiator, or a photoinitiator, or (2) two or more radical initiators, thermal initiators, or a photoinitiators. 24. The liquid adhesive complex coacervate of claim 23 , wherein the photoinitiator and optionally a co-initiator are covalently attached to the polycation and/or polyanion. 25. The liquid adhesive complex coacervate of claim 23 , wherein the photoinitiator comprises a water-soluble initiator comprising riboflavin, eosin, eosin y, or rose Bengal. 26. The liquid adhesive complex coacervate of claim 23 , wherein the photoinitiator comprises a phosphine oxide, a peroxide, an azide compound, an α-hydroxyketone, or an α-aminoketone. 27. A method for inhibiting blood flow in a blood vessel of a subject comprising introducing the liquid adhesive complex coacervate of claim 1 into the vessel. 28. A method for repairing a bone fracture in a subject, comprising contacting the fractured bone with the liquid adhesive complex coacervate of claim 1 . 29. A method for adhering a metal substrate to a bone of a subject comprising contacting the bone with the liquid adhesive complex coacervate of claim 1 and applying the metal substrate to the coated bone. 30. A method for adhering a bone-tissue scaffold to a bone of a subject comprising contacting the bone and tissue with the liquid adhesive complex coacervate of claim 1 and applying the bone-tissue scaffold to the bone and tissue. 31. A method for delivering one or more bioactive agents comprising administering the liquid adhesive complex coacervate of claim 1 to a subject. 32. A method for repairing a laceration, comprising applying to the laceration the liquid adhesive complex coacervate of claim 1 . 33. A method for securing a dental implant, comprising (a) applying to an oral substrate and/or dental implant the liquid complex coacervate of claim 1 , and (b) attaching the dental implant to the substrate.
for bone diseases, e.g. rachitism, Paget's disease · CPC title
Mixtures of macromolecular compounds · CPC title
Medicaments; Biocides · CPC title
Homopolymers or copolymers of acrylamide or methacrylamide · CPC title
Encapsulated active agents, e.g. emulsified droplets · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.